Vaccination practice in children with rheumatic disease

Revista Brasileira de Reumatologia

Volumn 50, Issue 4, 2010, Pages 356-361

  Silva, Clovis Artur A ^a   Terreri, Maria Teresa R A ^b   Aikawa, Nadia E ^a   Carvalho, Jozélio F ^a   Pileggi, Gecilmara C S ^a   Ferriani, Virginia P L ^a   Barbosa, Cássia Maria P L ^b   Hilário, Maria Odete E ^b   Jesus, Adriana A ^a   Sallum, Adriana M E ^a   Lotito, Ana Paola N ^a   Liphaus, Bernadete L ^a   Magalhães, Claudia S ^c   Len, Cláudio A ^b   Okuda, Eunice M ^d   Campos, Lucia Maria M ^a   Carvalho, Luciana M ^a   Ronchezel, Marcos Vinícius ^d   dos Santos, Maria Carolina ^d   Romanelli, Paulo Roberto S ^e   Marini, Roberto ^f   Pereira, Rosa Maria R ^a   Sacchetti, Silvana B ^d   Lotufo, Simone ^e   Bastos, Wanda A ^d   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d Faculdade de Medicina de Ribeirão Preto of Universidade de São Paulo ^*  (Brazil)

^e Hospital Municipal Infantil Menino Jesus   (Brazil)

^f UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Children; Juvenile idiopathic arthritis; Rheumatic disease; Systemic lupus erythematosus; Vaccination

Indexed keywords

AZATHIOPRINE; CHICKENPOX VACCINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HAEMOPHILUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HYDROXYCHLOROQUINE; INACTIVATED VACCINE; INFLUENZA VACCINE; LEFLUNOMIDE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGITIS VACCINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; PREDNISONE; SALAZOSULFAPYRIDINE; YELLOW FEVER VACCINE;

ARTICLE; BRAZIL; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DERMATOMYOSITIS; HUMAN; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; QUESTIONNAIRE; RHEUMATIC DISEASE; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION; PEDIATRICS; STATISTICS;

CHILD; HUMANS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; RHEUMATIC DISEASES; RHEUMATOLOGY; VACCINATION;

EID: 77957223474     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Len CA, Terreri MT, Hilário MO. Lúpus eritematoso sistêmico juvenil e infecção. Rev Bras Reumatol 2002; 42(4):218-22.
2. Facó MM, Leone C, Campos LM, Febrônio MV, Marques HH, Silva CA. Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus. Braz J Med Biol Res 2007; 40(7):993-1002.
3. Facó MM, Nukumizu LA, Pantoja AJ, Barros PC, Troster EJ, Silva CA. Avaliação dos óbitos e necropsias em pacientes internados em um Serviço de Reumatologia Pediátrica por um período de dez anos. Rev Bras Reumatol 2005; 45(2):55-63.
4. O' Neill SG, Isenberg DA. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus 2006; 15(11):778-783.
5. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008; 46(9):1459-1465.
6. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmunity Reviews 2008; 8(2):124-128.
7. Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 1999; 38(10):978-983.
8. Silva CA, Terreri MT, Barbosa CM, Hilário MO, Pillegi GS, Ferriani VP et al. Consenso de imunização para crianças e adolescentes com doenças reumáticas. Rev Bras Reumatol 2009; 49(5):562-589.
9. Davies K, Woo P. Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) 2002; 41:937-941.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40(9):1725.
11. Petty RE, Southwood T, Manners P, Baum J, Glass DN, Goldenberg J et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31(2):390-392.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292(7):344.
13. Delbecq AL, Van de Ven AH, Gustafson DH (ed.). Group Technique for Program Planning - a Guide to Nominal Group and Delphi processes. Glenview, Illinois. Scott, Foresman and Company, 1975.
14. American Academy of Pediatrics. Committee of Infectious Diseases. Varicella-zoster infections circunstances. In: LK P (ed.)r. Red Book. 27 ed. Elk Grove Village, IL; 2005: p.672-686.
15. Cush JJ, Calabrese L, Kavanaugh A. Herpes zoster (shingles) vaccine guidelines for immunosuppressed patients. American College of Rheumatology: Hotline 2008; Aug 1.
16. Marie I. Infections in polymyositis and in dermatomyositis. Presse Med 2009; 38(2):303-16.
17. Snowden N. Immunisation of immunosuppressed patients with rheumatic diseases. www.arc.org.uk/arthinfo/medpub/6632/6632.asp [cited 2007].
18. Luz KR, Souza DC, Ciconelli RM. Vacinação em pacientes imunossuprimidos e com doenças reumatológicas auto-imunes. Rev Bras Reumatol 2007; 47(2):106-113.
19. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde, Departamento de Vigilância e Epidemiologia, Programa Nacional de Imunizações. Manual dos Centros de Referência para Imunobiológicos Especiais (Cries). 2006. Disponível em: http://www.cve.saude.sp.gov.br/. Acesso em 20 de março de 2009.
20. Neves PS, Facó MM, Sallum AME, Campos LMA, Rossi Júnior A, Silva CA. Herpes zoster em pacientes com lúpus eritematoso sistêmico juvenil. Rev Bras Reumatol 2007; 47(2):135-139.
21. Bricks LF, Silva CA. Uso e abuso de anti-inflamatórios não hormonais: Parte I. Pediatria (São Paulo) 2005; 27(2):114-125.
22. Bricks LF, Silva CA. Toxicidade dos anti-inflamatórios não hormonais (AINH). Pediatria (São Paulo) 2005; 27(3):181-193.
23. Silva CA, Silva CH, Robazzi TC, Lotito AP, Mendroni Junior A, Jacob CM, et al. Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis. J Pediatr (Rio J) 2004; 80(6):517-522.
24. Pileggi GC, Souza CBS, Ferriani, VPL. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases using methotrexate and glucocorticoids. Arthritis Care Res (Hoboken) 2010 (in press).
25. Mota LM, Oliveira AC, Lima RA, Santos-Neto LL, Tauil PL. Vaccination against yellow fever among patients on imunossupressors with diagnoses of rheumatic diseases. Rev Soc Bras Med Trop 2009; 42(1):23-27.